secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2025-09-17T23:59:59+00:00
Accession:  0001753926-25-001510
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani sets Oct 8 record date for Cortigent spin-off; Cortigent to trade as CRGT
--------------------------------------------------------------------------------

- Record date for Cortigent spin-off is October 8, 2025; distribution date and ratio to be announced later.
- Spin-off expected to complete by late-2025; Cortigent will trade on Nasdaq under ticker CRGT.
- Cortigent develops brain implants (Orion vision system, stroke recovery device); has completed 6-year feasibility study.
- Post spin-off, Vivani focuses on ultra long-acting GLP-1 implants for weight loss and type 2 diabetes.
- Management teams will each focus on their respective strategies; Cortigent CEO Jonathan Adams to stay on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625001510/0001753926-25-001510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625001510/vani-20250917.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-001510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer